To investigate antioxidant effects of tea tree root extracts using various extraction methods, cytotoxicity, DPPH and ABTS radical scavenging, SOD, nitrite scavenging activity and inhibitory activity of lipid peroxidation, reducing power, ferrous ion chelating activity were measured. Cytotoxicity for RAW 264.7 cells was not observed at concentrations treated with below 90 μg/mL in all extracts. The maximum DPPH radical, nitrite scavenging, SOD activity and inhibitory activity of lipid peroxidation were obtained at the ethylacetate and 70% ethanol extract. The maximum ABTS radical scavenging activity was obtained at the ethylacetate and hot water extract. However, in the case of reducing power and ferrous ion chelating activity, they were obtained at 70% ethanol and hexane extract, respectively. Nitrate scavenging activity showed the most excellent scavenging ability of 59.6% at 90 μg/mL of ethylacetate. The hexane extract had the highest ferrous ion chelating activity, showing 61.05% at 50 μg/mL, 66.07% at 70 μg/mL and 76.81% at 90 μg/mL, respectively. The results of this research show that the ethylacetate and 70% ethanol extracts of tea tree root can be used as a natural material for scavenging the radicals. However, future study is necessary to understand the mechanism of antioxidant activity by identification of substances.

This study was conducted to determine the proximate compositions, nutritional components, and antioxidant effects of white and brown enoki mushrooms (Flammulina velutipes). The crude protein and carbohydrate contents were higher in the brown than white mushrooms, whereas the moisture, crude ash, crude lipid, and dietary fiber levels were lower. The mineral contents of the white mushroom was higher than levels obtained in the brown mushroom for the detected components (Ca, Cu, K, Mn, Na, and P). The amount of vitamin B3 in the brown mushroom was 1.51 mg/100 g, which was 4.5 times higher than that in the white mushroom. The major fatty acids detected were palmitic acid, linoleic acid, and α-linolenic acid. The total polyphenol and flavonoid contents were highest in 70% ethanol extracts of the white and brown mushrooms, respectively. For the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, a 70% methanol extract of the white enoki mushrooms showed an activity of 76.4% (p<0.05). For the ferric-reducing antioxidant power (FRAP) activity, a 70% methanol extract of the brown enoki mushrooms showed the highest value. Further, the total flavonoid contents were significantly correlated with the DPPH and FRAP activities.

Ulva compressa Linnaeus (UCL) is a green algae seaweed that performs photosynthesis and is used as a food material in some Asian regions including Korea. It is known to be the dominant species in copper ion-contaminated seas, and many studies on copper ion resistant mechanisms have been reported. UCL is known to have an excellent antioxidant effect, but limited information is available regarding its other physiological activities. In this study, we investigated the anticancer activity of 30% prethanol extracts of Ulva compressa Linnaeus (30% PeUCL) and the underlying mechanisms of its activity on human FaDu hypopharyngeal squamous carcinoma cells. The 30% PeUCL extracts suppressed FaDu cell viability without affecting normal cells (L929), as determined by MTT and viability assays. Furthermore, the 30% PeUCL extracts induced apoptosis, as determined by DAPI staining. The 30% PeUCL extracts inhibited colony formation effectively as well as wound-healing of FaDu cells, even at noncytotoxic concentrations. In addition, 30% PeUCL extracts induced apoptosis significantly through proteolytic cleavage of caspase-3, -7, and -9, and poly (ADP-ribose) polymerase, and by downregulation of Bcl-2 and upregulation of Bax in FaDu cells, as determined by Western blot analysis. Collectively, these results suggest that the inhibitory effect of 30% PeUCL extracts on the growth of oral cancer cells, colony formation and wound-healing may be mediated by caspase- and mitochondrial-dependent apoptotic pathways in human FaDu hypopharyngeal squamous carcinoma cells. Therefore, 30% PeUCL extracts can be administered as a natural chemotherapeutic drug for the treatment of human oral cancers.

본 연구의 목표는 S. boulardii 유래 세포벽 추출물 (CWSB)의 첨가가 반추위 발효에 미치는 영향을 평가하는 것이다. 본 연구의 in vitro 발효 실험은 CWSB의 첨가용 량이 다른 2개의 실험으로 구성되었다. 실험 1에서는 대 조구(CON, 시험사료)와 CWSB0.05(시험사료+CWSB 0.5g/kg 첨가), CWSB0.075(시험사료+CWSB 0.75g/kg 첨 가)의 처리구로 구성되었고, 실험 2의 처리구는 대조구 (CON, 시험사료)와 CWSB0.5(시험사료+ CWSB 5g/kg 첨 가), CWSB1.0(시험사료+CWSB 10g/kg 첨가)의 처리구로 구성되었다. In vitro 배양 이후 3, 6, 12, 24, 48h 동안 발 생한 가스 발생량 및 48h 배양 이후 발효 성상을 분석하 였다. 실험 1에서는 CWSB0.05 처리구에서 유의적으로 높 았던 Vmax(p<0.01)를 제외한 모든 반추위 발효성상에서 처 리구간 유의적 차이가 관찰되지 않았고, 이에 따라 사료 내 0.5%, 1%의 고용량 첨가 수준을 설정한 실험 2를 수행 하였다. 실험 2에서의 CWSB1.0 처리구는 대조구에 비해 총 VFA 발생량이 유의적으로 높았으나 전체 배양시간 내 가스 발생량 및 건물 소화율, 섬유소 소화율은 대조구와 유의적인 차이를 나타내지 않았다. 본 연구 결과를 종합 해 볼 때, CWSB의 첨가수준은 0.5% 이상에서 반추위 발 효 개선효과를 나타낼 것으로 추정된다.

The structure of isoflavone moiety in soybean could be altered by thermal treatment. Thus, this study analyzed the isoflavone profiles of raw soybean extract (RSe, no pretreatment), blanched soybean extract (BSe, at 85oC for 3 min), and cooked soybean extract (CSe, at 95oC for 30 min) and measured their α-glucosidase inhibitory activities. The content of malonylglucosides in RSe decreased considerably during their transformation into BSe and CSe. The total content of isoflavones in RSe and BSe was fairly similar, although there was a significant difference in the respective values for RSe and CSe. It was concluded that the cooking treatment significantly impacted soybean isoflavone content and, eventually, one-quarter of isoflavones were lost in CSe. According to authentic isoflavone tests, the inhibition of α-glucosidase by isoflavone aglycones was more effective than that of the corresponding isoflavone glucosides. The α-glucosidase inhibitions were observed in the order of BSe (70.0%), CSe (53.3%), and RSe (32.3%). However, it was challenging to identify which isoflavone derivative had contributed to the phenomenon mentioned above. Hence, the blanching of soybean seemed to be more appropriate than cooking for preparing soybean extract to inhibit α-glucosidase due to the higher loss of isoflavone during cooking.

본 연구는 붉나무와 참죽나무 추출물을 이용하여 딸기 흰가루병에 대한 천연 방제제의 방제 효과를 규명하기 위해 수행하였다. 딸기 흰가루병 친환경 방제제 개발을 위해 총 30종의 약용작물 추출물로 흰가루병 방제 효과를 시험한 결과 최종적으로 붉나무와 참죽나무 추출물을 선발하였다. 붉나무와 참죽나무 추출물을 단용 처리 시 방제가는 50~70% 범위로 일반 살균제보다 낮았다. 따라서 흰가루병 방제에 효과가 있다고 보고되고 있는 규산칼륨과 추출물을 혼용 처리하여 실험한 결과 방제 효과가 살균제와 비슷한 수준의 86%로 증대되었다. 규산칼륨과 추출물의 농도에 따른 방제 효과를 확인한 결과, 0.5%의 규산칼륨과 1,000배의 추출물이 적정 농도였다. 살포 횟수에 따른 방제 효과를 규명하기 위해 1회와 2회 처리를 실시한 결과 1회 처리 시 방제 효과가 13~14일로 나타났고, 3~4일 간격으로 2회 살포할 경우 30일 가량의 방제 기간을 가져 1회 처리보다 방제 효과가 더 우수하여 딸기 수확기 살균제 처리를 할 수 없는 기간에 방제가 가능한 것으로 나타났다.

본 연구에서는 화장품 천연소재로서 해죽순 열수 추출물의 이용 가능성을 확인하였다. tyrosinase 저해활성을 측정한 결과 1,000 μg/mL에서 52.0%의 활성을 나타내었다. 세포 생존율을 MTT 분석법으로 확인한 결과 멜라노마 세포(B16F10)의 농도 구간이 100 μg/mL 일 때 84.8%의 생존 율을 보였다. Western blot을 통한 단백질 발현 억제 효과를 측정하기 위해 25, 50, 100 μg/mL 농도의 해죽순 열수 추출물과 β-actin을 사용하였다. 그 결과, MITF, TRP-1, TRP-2, tyrosinase의 단백질 발 현양이 100 μg/mL에서 70.7%, 83.3%, 45.7%, 45.9%로 억제됨을 확인하였다. 따라서 해죽순 열수 추 출물의 미백효과가 우수함을 확인하였고, 해죽순 열수 추출물의 화장품 소재로서의 가능성을 확인하였 다.

Hepatic diseases are divided into two types: alcoholic and non-alcoholic. Non-alcoholic liver injury finally induces fatty liver and damages liver function. Many studies have demonstrated that Ecklonia stolonifera has antioxidative, antiinflammatory, and hepatoprotective activities. We conducted a 12-week double-blind, placebo-controlled, randomized trial to examine the efficacy of E. stolonifera extracts (ESE) on biochemical markers of hepatic function. Sixty-five subjects with mild or moderate liver injuries were randomly allocated to receive either 420 mg/d of ESE or a placebo for 12 weeks. Fifty-five participants completed the trial. No significant adverse events were observed among the subjects during the study. The primary end points were changes in plasma levels of aspartate transaminase (AST), alanine transaminase (ALT), and γ-glutamyltransferase (γ-GT). The secondary end points were changes in lipid profile levels, including total cholesterol (TC), triglyceride (TG), highdensity lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL). Compared with the baseline, AST and ALT levels decreased significantly in the ESE group compared to those in the placebo group (P<0.001). In addition, γ-GT levels in the ESE group were significantly lower than those in the placebo group (P=0.016). There were no differences in the TC, TG, HDL, and LDL levels between groups. In conclusion, ESE consumption for 12 weeks improved liver parameters in subjects with liver injury. Regular consumption of ESE could maintain liver health in individuals at risk of hepatic damage.

Asthma is a chronic inflammatory disease characterized by recurring symptoms, airflow obstruction, and bronchial hyper-responsiveness. The onset of asthma for most patients begins early in life, and current asthma treatment with anti-inflammatory agents can have adverse effects, eventually leading to impaired quality of life. In the pathogenesis of asthma, macrophages and basophils play a vital role during progression. Macrophages not only induce inflammation by secreting inflammatory cytokines but also promote DNA damage and mucus production through nitric oxide (NO) production. Basophils enhance eosinophil recruitment and aggravate asthma through the FcεRIα receptor with high affinity for histamine and IgE. Therefore, in this study, we investigated whether the activation of macrophages and basophils is suppressed by the individual extracts of 28 natural products. RAW 264.7 cells (mouse macrophages) were treated with the natural products in LPS, and 4 natural product extracts resulted in decreased NO production. In β-hexosaminidase assay using RBL-2H3 cells (rat basophils), 19 natural product extracts decreased β-hexosaminidase production. In NO production and β-hexosaminidase assay using macrophages and basophils, 3 natural product extracts (Plantago asiatica, Centella asiatica, and Perilla frutescens var. japonica) significantly inhibited NO production and β-hexosaminidase release. Overall, we examined the inhibitory effects of 28 natural product extracts on macrophage and basophil activity, and the findings demonstrated the potential of natural product extracts for treating asthma and macrophage- and basophil-related diseases.

본 연구에서는, 5가지 식물의 메탄올 추출물을 이용하여 모기기피 효과 실험을 진행하고 누드 쥐를 모델로 하여 흰줄숲모기에 대한 모기기 피제의 유효용량 및 유효시간을 평가하였다. 그리고 식물의 휘발성분을 GC-MS로 분석하였다. 유효용량은 개박하가 10, 50, 100, 200 μg/mL 에서 72.9, 83.7, 86.4, 97.3%의 효율로 가장 높았다. 누드 쥐를 대상으로 한 유효시간 연구에서는 5가지 식물의 메탄올 추출물 중 개박하, 개다 래 및 개똥쑥이 90.5%로, 30분까지만 지속하였다. 각 식물의 휘발성분을 분석한 결과, 애플민트 28개 성분, 개다래 19개 성분, 개똥쑥 27개 성분, 개박하 26개 성분, 민들레 19개 성분이 확인 되었다. 특히 모기기피제의 유효 성분으로 알려진 네페탈락톤(nepetalactone)이 개박하의 휘발성분 중 한 성분으로 확인 되었다(27.95 mg/Kg). 본 연구결과는 다양한 휘발성분을 함유한 식물을 이용한 모기기피제 재료로서 가능성을 제시한다.

Bulbophyllum auricomum Lindl. is a rare orchid and has flowers with an attractive fragrance. The present study investigated the tissue culture method for micropropagation. Capsules derived from artificial self-pollination were obtained for the best seed germination in MS basal medium. Plant growth regulators (1.0 mg·L-1 of BAP and 2.0 mg·L-1 of NAA) were affected by callus induction from subcultured pseudobulb explants. For the callus subculture, different natural plant extracts were tested in 11 treatment media. Among them, MS medium with 150 mL·L-1 of coconut water was generally effective in fresh weight (1.75 ± 0.08) and (3.01 ± 0.20) of callus proliferation and PLBs induction at 1 and 2 months, respectively, followed by an MS combination of 30 g·L-1 of banana and 20 g·L-1 of potato extract. The results of a comparative study of different MS mediums containing plant growth regulators with a natural extract combination and MS medium supplemented with natural extract only showed that MS medium supplemented with a combination of natural extracts (150 mL·L-1 of coconut water) and plant growth regulators (2.0 mg·L-1 of BAP and 1.0 mg·L-1 of NAA) obtained the highest shoot regeneration (3.37 ± 0.17) and (6.41 ± 0.68) after 1 month and 2 months of culturing, respectively.

The antioxidant effects by pre-treatment of Hutgae fruit water and ethanol (30°, Soju) extract on refrigerated eels were analyzed. The antioxidant activities were measured through DPPH and ABTS scavenging effect, values of acidity, peroxide, carbonyl, and TBA. The peroxide prevention effects of linoleic acid and eel oil were also assessed. Regarding DPPH radical scavenging, Hutgae ethanol extract presented higher scavenging effects than vitamin C 5 mM solution (p<0.05). The eel’s peroxidation degree was measured through 21 days of refrigeration after cleaning and immersion into the extract solution for one hour. Upon measuring the values of four different peroxide indicators, those of eels pre-treated with Hutgae extracts were lower than those of eels untreated. The POV of Hutgae ethanol extract, vitamin C 5 mM, and the control was 11.1, 11.3, 15.5 meq/kg, respectively. Hutgae ethanol extract showed higher antioxidant activities in TBA value, and carbonyl value than other samples. In linoleic acid or eel oil, Hutgae extract was as superiorly effective in preventing peroxide generation of refrigerated eels as vitamin C 10 mM solution. In conclusion, pre-application of Hutgae water and ethanol (30°, Soju) extract on eels was proved to be competent in stopping peroxidation of eel in refrigeration.

수산물을 활용한 반려묘 간식개발을 위하여 명태, 조피볼락, 넙치, 돌돔, 연어 및 참치 등의 부산물을 고압고온에서 삶아 그 농축액을 반려묘에게 급여하였다. 반려묘의 기호도가 높은 실험구는 연어와 참치 농축액이었다. 여기에 통영에서 생산되는 멸치, 홍합 및 굴 건조물을 분쇄하여 첨가한 결과 모든 구에서 섭식행동을 나타내었다. 시중에 판매되고 있는 기존의 반려묘 간식과 차별화를 위하여 멍게껍질에 함유된 콘드로이친황산(ChS)을 추출하고 일정량을 연어 및 참치 농축액에 첨가하여 섭식을 실험한 결과 모두 잘 먹는 것으로 나타났다. 과잉생산 된 수산건제품을 반려묘 간식 개발에 활용할 수 있어 수산부산물의 활용방안을 제시할 수 있을 것으로 판단된다.

Functional dyspepsia (FD) is a gastrointestinal disorder with diverse symptoms but no structural or organic manifestations. Benachio-F® (herein named ‘BF-1’) is an over-the-counter liquid digestive formulated with multiple herbal extracts, which has been reported to improve symptoms of FD. A total two experiments were conducted. First, we examined whether BF-1 can modulate the progression of FD through two experimental rat models. A total of three doses (0.3x, 1x, 3x of the human equivalent dose) were used. In the gastric emptying model, both 1x (standard) or 3x (3-fold-concentrated) BF-1 enhanced gastric emptying was compared with that of vehicle-treated animals. In a feeding inhibition model induced by acute restraint stress, treatment with 1x or 3x BF-1 led to a similar degree of restoration in food intake that was comparable to that of acotiamide-treated animals. Among the constituents of BF, fennel is known for its choleretic effect. Thus, we next investigated whether a novel BF-based formula (named ‘BF-2’) that contains an increased amount of fennel extract (3.5-fold over BF-1), has greater potency in increasing bile flow. BF-2 showed a superior choleretic effect compared to BF-1. Furthermore, the postprandial concentration of serum secretin was higher in animals pretreated with BF-2 than in those pretreated with BF-1, suggesting that the increased choleretic effect of BF-2 is related to secretin production. Our results demonstrate that BF-1 can modulate the pathophysiological mechanisms of FD by exerting prokinetic and stress-relieving effects, and that BF-2 has a better choleretic effect than BF-1.